Her main research interests include personalized dosimetry, radionuclide therapy, radioembolization, quantitative imaging, artificial intelligence applied to imaging and therapy, and clinical radiobiology.
Her scientific activity focuses particularly on the development and validation of quantitative, dosimetric, and radiobiological models for treatment personalization, the investigation of dose-response relationships, and the assessment of treatment response.
She is involved in national and international research projects in oncology, nuclear medicine, quantitative imaging, and artificial intelligence, and participates in European and international scientific working groups and committees. She has also contributed to the development of international scientific guidelines and documents in the fields of dosimetry and radiopharmaceutical therapy.
